Sun Pharma is the largest and most valuable pharmaceutical company in India, and also the fourth largest professional generic drug manufacturer globally. Active Pharmaceutical Ingredient (API): Through its subsidiary, Sun Pharma Advanced Research Company (SPARC), the company conducts research and development of new drugs and complex APIs. Some of its innovative drug pipelines have entered the clinical phase (such as new molecular entities for the treatment of psoriasis and dry eye syndrome). I

It is one of the top five first-tier pharmaceutical giants in India, belonging to the same first-tier group as Lupin and Sun Pharma. The biggest difference between it and other Indian pharmaceutical companies is that it is one of the few large family-owned enterprises in India that master the entire industry chain of "vaccine research and development + biologics + conventional generic drugs".

Founded in 1916, with a history spanning a century. Business composition: The company's business is divided into two pillars: functional chemicals (dyes, resins, electronic materials) and pharmaceuticals. Pharmaceutical revenue accounts for approximately 40% to 50% of the company's total revenue. Parent company nature: It belongs to the traditional "integrated chemical giant" category in Japan, and is in the same league as Sumitomo Chemical and Mitsubishi Chemical.

Current company: Viatris (Huizhi) - a global Top 10 generic drug giant. Indian Base: Located in Hyderabad, Mumbai, and other places, it boasts over 10 FDA-certified factories and serves as the core hub of Viatris' global supply chain. Over 70% of the products for the US market are supplied by Indian factories.

Lupin is one of the top multinational pharmaceutical giants in India, not on the same scale as NATCO and Sunrise mentioned earlier. Its core positioning is as the world's largest supplier of tuberculosis (TB) drugs and a major force in the US generic drug market.

A medium-sized generic drug formulation manufacturer headquartered in Ahmedabad, Gujarat, India. Business characteristics: The company primarily produces tablets, capsules, injections, and topical preparations, covering therapeutic areas such as antibiotics, gastroenterology, pain management, and nutritional supplements. Market positioning: Primarily export-oriented, with products sold to emerging markets such as Africa, Southeast Asia, and Latin America. Although not considered a top-tier man

NATCO (Natco Pharma) is a medium-sized pharmaceutical company in India renowned for producing generic versions of high-priced patented drugs. Its headquarters is located in Hyderabad. It has gained global recognition for repeatedly producing and selling affordable versions of cancer drugs (such as Nexavar and Regorafenib) from foreign giants, in accordance with the compulsory licensing provisions of the Indian Patent Act. It is regarded as a "patent challenger" and a "promoter of affordable drug